Gene Editing by Cystolic Intracellular Delivery

Exclusively Licensed

Gene editing can be performed by introducing gene-editing components into a cell by mechanical cell disruption. Related apparatus, systems, techniques, and articles are also described.

Researchers

Robert Langer / Alexandra Eyerman / Prashant Mali / Marc Lajoie / Armon Sharei / Klavs F. Jensen

Departments: Office of the Institute Professors, Department of Chemical Engineering
Technology Areas: Biotechnology: Biomedical Devices & Systems, DNA & RNA Editing / Drug Discovery and Research Tools: Cell Interrogation
Impact Areas: Healthy Living

  • gene editing through microfluidic delivery
    United States of America | Granted | 12,130,281
  • gene editing by cystolic intracellular delivery
    Canada | Published application
  • gene editing by cystolic intracellular delivery
    Australia | Granted | 2,016,206,870
  • gene editing by cystolic intracellular delivery
    European Patent Convention | Published application
  • gene editing through microfluidic delivery
    Japan | Granted | 7,278,027
  • gene editing through microfluidic delivery
    United States of America | Granted | 11,125,739
  • gene editing by cystolic intracellular delivery
    China | Published application
  • gene editing through microfluidic delivery
    Japan | Published application

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

More Technologies